Sunnyside Growth Partners Company Profile

Background

Sunnyside Growth Partners (SGP) is a privately held investment firm specializing in the acquisition and growth of small to mid-sized healthcare companies. Established on October 16, 2023, and headquartered in Hollywood, Florida, SGP is committed to identifying, acquiring, and fostering the growth of high-quality businesses within the healthcare sector. The firm emphasizes a transparent exit strategy for business owners, providing liquidity while preserving their legacy and enhancing their operations.

Key Strategic Focus

SGP's strategic focus includes:

Industry Focus: Healthcare and healthcare-adjacent sectors, particularly those that are fragmented and offer opportunities for consolidation.

Company Criteria: Targets businesses with Seller's Discretionary Earnings (SDE) between $750,000 and $1.5 million, preferably located in the South Florida region, though open to other areas.

Operational Characteristics: Seeks companies that are consistently profitable with comfortable margins, possess recurring revenue or patient base, and have high competitive barriers with growth potential.

Situational Considerations: Focuses on scenarios where owners are motivated to sell due to retirement or other non-business reasons, or where clinical owners seek buyers with both clinical and business expertise.

Financials and Funding

As a privately held entity, specific financial details and funding history of SGP are not publicly disclosed. The firm operates with a focus on acquiring and growing healthcare businesses, providing liquidity to business owners while preserving their legacy.

Pipeline Development

SGP's pipeline development strategy involves identifying and acquiring healthcare businesses that align with their strategic focus. The firm emphasizes a transparent and straightforward acquisition process, including an introductory call, preliminary offer, due diligence, closing, and transition phases. This approach ensures a smooth transition and continued growth for the acquired businesses.

Technological Platform and Innovation

While specific proprietary technologies or scientific methodologies employed by SGP are not publicly detailed, the firm leverages its co-founders' extensive experience in healthcare management and clinical operations to drive innovation and operational excellence within acquired companies.

Leadership Team

David Morpeau, MBA
Co-Founder and Managing Principal & Growth Operator
David is a recognized industry leader and venture investor dedicated to elevating healthcare standards. He holds an MBA in Healthcare Management and a BA in Biology from Florida International University. His career spans clinical operations, process improvement, management consulting, and venture investing. David serves as a board member for the American College of Healthcare Executives (ACHE) of South Florida and was honored with the 2022 Regent's Award.

Melissa Chamblain, MD
Co-Founder and Managing Principal & Clinical Operator
Dr. Chamblain is a Board-Certified Internist and Geriatrician committed to promoting healthcare literacy, wellness, and mentorship. Raised in Haiti, she pursued higher education in the United States, completing a geriatric fellowship at NYU Langone Hospital. She returned to South Florida to serve as a primary care provider for underserved populations. Dr. Chamblain actively participates in community outreach and mentorship programs and was honored with the Top Doctor 2023 award in Aventura Magazine's May 2023 issue.

Leadership Changes

As of the latest available information, there have been no significant changes or appointments within SGP's leadership team.

Competitor Profile

Market Insights and Dynamics
The healthcare investment sector is characterized by a growing demand for consolidation and operational efficiency, particularly in fragmented markets. The focus on acquiring and enhancing small to mid-sized healthcare businesses aligns with industry trends emphasizing quality care and financial sustainability.

Competitor Analysis
While specific direct competitors to SGP are not identified in the available information, the firm operates in a competitive landscape that includes private equity firms and investment companies targeting the healthcare sector. Competitors may focus on similar acquisition criteria, emphasizing profitability, growth potential, and operational excellence.

Strategic Collaborations and Partnerships

SGP's approach involves building close relationships with business owners to facilitate smooth transitions and growth. While specific partnerships are not detailed, the firm's emphasis on transparency and collaboration suggests a strategic focus on fostering strong alliances within the healthcare industry.

Operational Insights

SGP differentiates itself through a personalized and transparent acquisition process, leveraging the co-founders' extensive healthcare experience. This approach ensures that acquired businesses benefit from both clinical and business expertise, positioning them for sustained growth and success.

Strategic Opportunities and Future Directions

SGP is poised to capitalize on opportunities within the healthcare sector by focusing on acquiring businesses with strong fundamentals and growth potential. The firm's commitment to preserving the legacy of acquired companies while enhancing their operations positions it as a preferred partner for business owners seeking a strategic exit.